Clinical Study on the Mass Balance of Clifutinib

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

September 29, 2025

Primary Completion Date

January 21, 2026

Study Completion Date

January 28, 2026

Conditions
Healthy Adult Male
Interventions
DRUG

[14C]Clifutinib

The subjects are required to take the test drug on an empty stomach for at least 10 hours and without drinking water for 1 hour. After taking the drug, they should fast for 4 hours and refrain from drinking water for 1 hour.

Trial Locations (1)

214000

Affiliated hospital of Jiangnan University, Wuxi

All Listed Sponsors
lead

Sunshine Lake Pharma Co., Ltd.

INDUSTRY